Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies
Maurizio Fava(Unknown), Sanjeev Pathak(Alkermes (United States)), Elliot Ehrich(McLean Hospital), Aslı Memişoğlu(McLean Hospital), Madhukar H. Trivedi(Southwestern Medical Center), Michael E. Thase(Veterans Health Administration), Miao Yu(Alkermes (United States)), Arielle D. Stanford(Alkermes (United States)), William Martin(Alkermes (United States)), Narinder Nangia(Alkermes (United States))
Cited by 83
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
|Psychological Medicine|2004|989